MUTZ: Daniels’ plans for Purdue will range wide
Predicting what Daniels will tackle is as risky as second-guessing a U.S. Supreme Court decision.
Home » Search
Search Results
13,419 results for 'IU Indianapolis'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
VANE: Bennett can tout list of accomplishments
The state superintendent of public instruction’s race may be the most crucial contest this fall.
CIB mulling sale of historic downtown building
The Capital Improvement Board has owned the Ober building, at 107 S. Pennsylvania St. near Bankers Life Fieldhouse, since 1999. Members on Monday voted to begin soliciting bids.
Old National names ex-Indiana chief justice as director
Old National Bancorp has appointed former Indiana Chief Justice Randall Shepard to its board of directors.
Local providers join Medicare ACO program
Indiana University Health, as well as a partnership of Franciscan Alliance and American Health Network, have formed accountable care organizations that won the blessing of the federal Medicare Shared Savings program.
WellPoint shares jump after $4.9B deal for Amerigroup
Investors and analysts like the fact that WellPoint is playing more aggressively in government-sponsored health plans, such as Medicaid and Medicare, which are projected to be the key sectors for growth for the next several years.
New track-and-field chief aims to end sport’s strife
New USA Track and Field CEO Max Siegel is promising to pull athletes, their agents, sponsors, event promoters and the sport’s television partners together to lift track and field’s tainted image and revenue—especially domestically.
HETRICK: Maybe it’s time to think like ‘Mad Men’ and sell everything
The Rs and the Ds could fight over ad space in voter registration.
Heartland Bancshares approves acquisition by Horizon
The deal, effective July 17, will give the Michigan City bank its first presence in Central Indiana.
Council mulls axing applications’ prior-conviction box
City-County Councilor Vop Osili thinks the city could level the job-seeking playing field for ex-offenders by eliminating the question of past convictions on job applications.
Also this week
Zac Brown Band performs July 7 at Klipsch Music Center. Details here.
“Bringing Up Baby,” with Cary Grant and Katharine Hepburn, screens July 6 at the Indianapolis Museum of Art. Details here.
Wynonna and Steel Magnolia replace the daily double at Hoosier Park Racing & Casino July 7. Details here.
Gamers and science fiction/fantasy fans gather at InConjunction, July 6-8 at the Marriott East. Details here. (And I’ll be serving as toastmaster/charity auctioneer.)
“Let’s Dance,” July 7 at the Indiana State Museum, features square dancers from around the state. Details here.
IU Summer Theatre Festival continues with “The Taming of the Shrew,” July 5-28, featuring guest artist Rob Johansen. Details here.
The Cowardly Scarecrow Theatre Company presents “Musical of the Living Dead,” July 6-7 at the Irving Theatre. Warning: The first few rows are designated as a “splatter zone.” Details here.
UPDATE: BrightPoint sale follows tough stretch for firm
Given the soft cell phone market and Brightpoint’s recent struggles, a sale to California-based Ingram Micro for about $840 million makes sense, analysts say. The two companies announced the acquisition early Monday morning.
UPDATE: Brightpoint’s planned sale spawns uncertainty
The $840M deal, which would eliminate one of Indiana’s six Fortune 500 companies, is casting uncertainty over Hendricks County, where the company is one of the largest employers.
BrightPoint to be acquired for $840M by California firm
Indianapolis-based BrightPoint Inc. has agreed to be acquired by California-based Ingram Micro Inc. for about $840 million, the two companies said early Monday morning.
Bristol-Myers to buy former Lilly partner Amylin for $5.3B
Bristol-Myers Squibb Co. has agreed to pay $5.3 billion to acquire former Eli Lilly and Co. partner Amylin Pharmaceuticals Inc., a maker of diabetes therapies. The deal is valued at about $7 billion, which includes Amylin’s debt and a payment to Eli Lilly and Co. of about $1.7 billion.
Company news
Covance Inc. is seeking state and local tax incentives as part of a $150 million expansion that would create 465 jobs at its Greenfield operations, nearly doubling the number of employees there. The proposed expansion would occur over the next four years and include the construction of a new laboratory, the renovation of existing buildings, and the hiring of administrative and laboratory personnel, according to the Daily Reporter in Greenfield. Princeton, N.J.-based Covance, a pharmaceutical research company, acquired Greenfield Labs from Eli Lilly and Co. in October 2008 for $50 million and a 10-year agreement from Lilly to use Covance’s services. At that time, 264 Lilly employees shifted to Covance. The company now employs 565 workers at the site, according to the newspaper. The Hancock County Council is set to hear Covance’s request for incentives July 11. Documents filed with the county show the 465 jobs would add $29 million in salaries with annual pay averaging more than $62,000 per employee, the Daily Reporter said. The company uses the Greenfield Laboratories to conduct early-stage tests of experimental drug molecules, readying them for tests in humans.
Officials from Indiana University Health Arnett broke ground on a facility in West Lafayette last week, according to the Journal and Courier of Lafayette. The new location, housed in a former Kmart store, will add outpatient imaging and expanded laboratory services to IU Health’s existing services in West Lafayette. The $8 million facility also will include an urgent care center with extended hours of operation. Indianapolis-based IU Health operates a full-scale hospital in Lafayette.
Dr. Yang Sun, an assistant professor of ophthalmology at the Glick Eye Institute, received a five-year, $1 million grant from the National Eye Institute to study congenital glaucoma with the hope of discovering new treatments for common forms of glaucoma. “Glaucoma is a leading cause of irreversible blindness in the world, yet the mechanisms of glaucoma development remain poorly understood, and treatments are limited,” Sun said. “I’m hoping to understand the mechanism of inherited congenital glaucoma, in the hopes that this will provide insight and potentially lead to novel treatments for commonly seen forms of glaucoma.”
Q&A
The U.S. Supreme Court’s ruling to uphold the Patient Protection & Affordable Care Act cleared a big cloud of uncertainty for employers, but with just 18 months before the most significant provisions of the law kick in, many questions remain. Three benefits consultants from Indianapolis-based Gregory & Appel Insurance—Bob Miller, Mike Miles and Karl Ahlrichs—sat down to discuss what the future looks like for employer health benefits.
Abound failure raises questions anew about Obama policies
The failure of a second solar manufacturer that received loan guarantees from the U.S. Energy Department adds to pressure on President Barack Obama to justify incentives for the clean-energy industry that’s being undercut by Chinese competition.
Lawsuit: Smulyan angling for Emmis buyout
Jeff Smulyan has been considering a new plan to buy out other Emmis Communications Corp. shareholders—a deal that could clear the way for him to finally take the Indianapolis media company private. But Emmis’ founder and CEO insists he has no plans to do so.